Literature DB >> 11587940

Towards elimination of lymphatic filariasis in India.

P K Das1, K D Ramaiah, D J Augustin, A Kumar.   

Abstract

The global initiatives to eliminate lymphatic filariasis as a public health problem by the year 2020 have generated a great deal of debate in India, the largest endemic country. This has led to a shift in the focus from control to elimination of the disease. Although the campaign to eliminate filariasis has begun, much more needs to be done. Several recent research studies have provided an insight into various operational issues and prospects of elimination of lymphatic filariasis. In this article, the current scenario, recent research results, logistics and the prospects of eliminating lymphatic filariasis in India will be discussed.

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11587940     DOI： 10.1016/s1471-4922(01)02056-6

Source DB:  PubMed          Journal:  Trends Parasitol        ISSN： 1471-4922


  9 in total

1.  High prevalence of Wuchereria bancrofti infection as detected by immunochromatographic card testing in five districts of Orissa, India, previously considered to be non-endemic.

Authors:  Patricia K Foo; Alessandro Tarozzi; Aprajit Mahajan; Joanne Yoong; Lakshmi Krishnan; Daniel Kopf; Brian G Blackburn
Journal:  Trans R Soc Trop Med Hyg       Date:  2010-11-30       Impact factor: 2.184

2.  The effect of compliance on the impact of mass drug administration for elimination of lymphatic filariasis in Egypt.

Authors:  Maged El-Setouhy; Khaled M Abd Elaziz; Hanan Helmy; Hoda A Farid; Hussein A Kamal; Reda M R Ramzy; William D Shannon; Gary J Weil
Journal:  Am J Trop Med Hyg       Date:  2007-12       Impact factor: 2.345

3.  Reduction in acute filariasis morbidity during a mass drug administration trial to eliminate lymphatic filariasis in Papua New Guinea.

Authors:  Daniel J Tisch; Neal D E Alexander; Benson Kiniboro; Henry Dagoro; Peter M Siba; Moses J Bockarie; Michael P Alpers; James W Kazura
Journal:  PLoS Negl Trop Dis       Date:  2011-07-12

4.  Brugia malayi adult low molecular weight IgG4-reactive antigens induce differential cytokine response in lymphocytes of endemic normal and asymptomatic microfilariae carriers in vitro.

Authors:  Bimal P Mohanty; Ramanuj Lahiri; Shailja Misra-Bhattacharya; Santosh K Kar
Journal:  J Clin Immunol       Date:  2007-03-20       Impact factor: 8.542

5.  Adverse drug effects among students following mass de-worming exercise involving administration of Praziquantel and Albendazole in KEEA Municipality, Ghana.

Authors:  Wisdom Akrasi; Augustine Suurinobah Brah; Mainprice Akuoko Essuman; Viona Osei; Alex Boye
Journal:  PLoS Negl Trop Dis       Date:  2022-09-12

6.  Advancing Sino-Indian cooperation to combat tropical diseases.

Authors:  Peter Hotez; Sunit K Singh; Xiao-Nong Zhou
Journal:  PLoS Negl Trop Dis       Date:  2013-09-26

7.  Triple co-administration of ivermectin, albendazole and praziquantel in zanzibar: a safety study.

Authors:  Khalfan A Mohammed; Hamad J Haji; Albis-Francesco Gabrielli; Likezo Mubila; Gautam Biswas; Lester Chitsulo; Mark H Bradley; Dirk Engels; Lorenzo Savioli; David H Molyneux
Journal:  PLoS Negl Trop Dis       Date:  2008-01-23

8.  Tolerability and efficacy of single dose albendazole, diethylcarbamazine citrate (DEC) or co-administration of albendazole with DEC in the clearance of Wuchereria bancrofti in asymptomatic microfilaraemic volunteers in Pondicherry, South India: a hospital-based study.

Authors:  SP Pani; G Subramanyam Reddy; LK Das; P Vanamail; SL Hoti; J Ramesh; PK Das
Journal:  Filaria J       Date:  2002-10-10

9.  Exploring factors affecting quality implementation of lymphatic filariasis mass drug administration in Bole and Central Gonja Districts in Northern Ghana.

Authors:  Alfred Kwesi Manyeh; Latifat Ibisomi; Rohit Ramaswamy; Frank Baiden; Tobias Chirwa
Journal:  PLoS Negl Trop Dis       Date:  2020-08-17
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.